Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis

[1]  L. Kruglyak.  Prospects for whole-genome linkage disequilibrium mapping of common disease genes , 1999, Nature Genetics.

[2]  V. Martinelli,et al.  Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients , 1999, Neurology.

[3]  C. Polman,et al.  Association of interleukin-1β and interleukin-1 receptor antagonist genes with disease severity in MS , 1999, Neurology.

[4]  G. Ebers.  McAlpine's Multiple Sclerosis , 1998 .

[5]  N. Camp,et al.  An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. , 1998, American journal of human genetics.

[6]  E. G. de la Concha,et al.  Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis , 1997, Journal of Neuroimmunology.

[7]  L. Peltonen,et al.  Immune system genes in multiple sclerosis: genetic association and linkage analyses on TCRβ, IGH, IFN-γ and IL-1ra/IL-1β loci , 1997, Journal of Neuroimmunology.

[8]  H. Przuntek,et al.  Genetic predisposition to multiple sclerosis as revealed by immunoprinting , 1997, Annals of neurology.

[9]  M. Clanet,et al.  Interleukin-1 receptor antagonist gene in multiple sclerosis , 1997, The Lancet.

[10]  T. Yousry,et al.  Multiple sclerosis: longitudinal measurement of interleukin-1 receptor antagonist. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[11]  W J Ewens,et al.  The TDT and other family-based tests for linkage disequilibrium and association. , 1996, American journal of human genetics.

[12]  P. Reitsma,et al.  Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. , 1996, Cytokine.

[13]  J. Hillert,et al.  An interleukin 1-receptor-antagonist gene polymorphism is not associated with multiple sclerosis , 1996, Journal of Neuroimmunology.

[14]  L Kruglyak,et al.  Parametric and nonparametric linkage analysis: a unified multipoint approach. , 1996, American journal of human genetics.

[15]  F. Nicoletti,et al.  Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment. , 1996, Cytokine.

[16]  J. Crusius,et al.  Allelic polymorphism in IL‐1β and IL‐1 receptor antagonist (IL‐1Ra) genes in inflammatory bowel disease , 1995, Clinical and experimental immunology.

[17]  C. Polman,et al.  Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis , 1995, The Lancet.

[18]  N. Risch,et al.  A comparison of linkage disequilibrium measures for fine-scale mapping. , 1995, Genomics.

[19]  D. Martin,et al.  Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats , 1995, Journal of Neuroimmunology.

[20]  D. Grennan,et al.  Cytokine production by normal human monocytes: inter‐subject variation and relationship to an IL‐1 receptor antagonist (IL‐1Ra) gene polymorphism , 1995, Clinical and experimental immunology.

[21]  J. Mansfield,et al.  Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. , 1994, Gastroenterology.

[22]  G. Duff,et al.  A Physical Map of the Region Encompassing the Human Interleukin-1α, Interleukin-1β, and Interleukin-1 Receptor Antagonist Genes , 1994 .

[23]  M. Cork,et al.  Psoriasis and Interleukin-1 , 1993, Journal of the Royal College of Physicians of London.

[24]  W. Ewens,et al.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.

[25]  A. Blakemore,et al.  Single base polymorphism at −511 in the human interleukin-1β gene (IL1β) , 1992 .

[26]  F. Pociot,et al.  A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro , 1992 .

[27]  W. Arend.  Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. , 1991, The Journal of clinical investigation.

[28]  C. Dinarello.  Interleukin-1 and interleukin-1 antagonism. , 1991, Blood.

[29]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[30]  S. Schneider.  Arlequin ver.1.1:a software for population genetic data analysis. , 1997 .